A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer

This is a study to determine the clinical benefit (how well the drug works), safety and tolerability of combining varlilumab and atezolizumab. Phase l of the study will enroll patients with a number of tumor types; Phase ll will enroll only patients with renal cell carcinoma (RCC).

Official Site 
Start/End Date 
October 1, 2015 to December 1, 2017
Varlilumab (CDX-1127)
Atezolizumab (MPDL3280A)
Phase 2

Add new comment

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.